EXPERT COMMENTARYWith Undertreatment Still Occurring, Funding From Big Pharma Isn't Necessarily InappropriateLyles, C. Alan MPH, ScD, RPh Author Information C. Alan Lyles, MPH, ScD, RPh, is the Henry A. Rosenberg Professor of Public, Private, and Nonprofit Partnerships at the University of Baltimore (UB). He is a professor in the UB College of Public Affairs' Health Systems Management Program and a senior fellow in the Center on Drugs and Public Policy at the University of Maryland School of Pharmacy. He is also a fellow of the National Academy of Public Administration and a docent of pharmaceutical policy and pharmacoeconomics at the University of Helsinki, Finland. As an international expert, Lyles is widely published in numerous peer-reviewed journals and frequently is invited by Topics in Pain Management to provide comment on pharmacy and health care policy issues. Disclosure: Dr. Lyles has consulted with government, nongovernmental organizations, and industry; however, this has not included pain management. Topics in Pain Management 28(1):p 10, August 2012. | DOI: 10.1097/01.TPM.0000418560.53631.1d Buy Metrics Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.